This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Blood Processing Supplies And Equipment Industry

Medical II-61

Fenwal Obtains US FDA Approval for Software II-62

Terumo Concludes Acquisition of CaridianBCT II-62

BD Acquires Carmel Pharma II-63

Fenwal Enters into an Agreement with GenesisBPS II-63

Sysmex Canada and Diagnostic Services of Manitoba Enter into

Agreement II-64

Fenwal, Golden Meditech to Form JV for Selling Blood

Collection Products in China II-64

BD Acquires Accuri Cytometers II-65

BioCurex and VetRed Enter into Cancer Test Distribution Agreement II-65

Haemonetics and Consorta Enter into Agreement II-65

Stago Group Acquires Coagulation Business of Trinity Biotech II-66

Haemonetics, Quotient Biodiagnostics Group and Alba Bioscience

Enter into Agreement II-66

Sekisui Chemical to Merge Shanghai Daiichi Diagnostics and

Sekisui Trank II-67

Haemonetics and Global Med Technologies Enter into Definitive

Acquisition Agreement II-67

Pall Enters into Agreement with ASI II-67

Fenwal Gains FDA Approval for ALYX™ System with Wireless-

Enabled Data Export Capabilities II-68

Fenwal Obtains US FDA Approval for ALYX Component Collection

System II-69

RFCL Limited, Diagon Ink Agreement II-69

Guangzhou Instruments Obtains FDA Clearance for New Serum Tube II-69

Cytomedix Signs Deal to Acquire Sorin's Angel System and

activAT Kit II-69

Sekisui Chemical to Combine Chinese Medical Subsidiaries II-70

15. CORPORATE ACTIVITY IN THE RECENT PAST - A HISTORIC PERSPECTIVEBUILDER II-71BD Diagnostics Receives FDA Approval for BD Vacutainer® RapidSerum Tube II-71Aurora to Acquire HLTH's Porex Corporation II-71Sysmex Secures FDA Approval for XE-2100D AHA II-71Fenwal to Establish JV with Golden Meditech for Blood-relatedTechnologies II-72Haemonetics Takes Over SEBRA Blood Collection and ProcessingAssets II-72UK Biobank Selects RTS' Automated Systems II-73NHSBT Deploys PK7300 Automatic Blood Grouping Solution II-73Hemo Bioscience Inks Distribution Agreement with ARC for BloodGrouping Reagents II-74Haemonetics Snaps Up Neoteric Technology II-74Shandong Taibang Divests Stake in Xi'an Huitian Blood Products II-74Haemonetics Acquires Altivation Software II-74Asahi Kasei Medical to Sign Agreement with TechniKrom II-75BioE Secures 510(k) FDA Approval for PrepaCyte®-CB II-75BCT Japan to Change Name to CaridianBCT II-75Escalon Medical Acquires Biocode Hycel's Hematology Business II-76American Red Cross and CaridianBCT Enter into Agreement II-76Gambro BCT Changes Official Name to CaridianBCT II-76Terumo and Hettich Enter into Global Pact for New BloodProcessing System II-76Haemonetics Acquires Haemoscope's Hemostasis Analyzer Business II-77Rheologics Technologies Purchases Cardiodyne Electronics II-77ThermoGenesis Makes 510(k) Appeal to FDA II-77ThermoGenesis To Deliver Technology To SCP for Research II-77Haemonetics Acquires Infonale II-78ViaCell Integrates Automation into Closed Blood Processing System II-78HTL-Strefa Wins 12 Million Contract II-78Biosafe Receives US FDA 510(k) Clearance for SEPAX II-78HMD To Expand Production Capacity II-78Quotient BioResearch Acquires Alba Bioscience II-79Fresenius Kabi to Acquire Kyorin's Blood Volume ReplacementOperations II-79Haemonetics Acquires Assets of IDM II-79Baxter Divests Transfusion Therapies Business II-80Immucor's Galileo Echo Receives FDA Clearance for Marketing II-80ThermoGenesis Submits Application to US FDA for NewAutoXpress™ System II-80

16. FOCUS ON SELECT GLOBAL PLAYERS II-82

5 of 22

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs